You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 9, September 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Articles for Residents
 •Dermatology
 •Herpes
 •Alert me on articles by topic

A Relationship Between Varicella-Zoster Virus–Specific Delayed Hypersensitivity and Varicella-Zoster Virus–Induced Anterior Uveitis

Takeshi Kezuka, MD, PhD; Jun-ichi Sakai, MD, PhD; Hiroshi Minoda, MD, PhD; Masaru Takeuchi, MD, PhD; Hiroshi Keino, MD, PhD; J. Wayne Streilein, MD; Masahiko Usui, MD, PhD

Arch Ophthalmol. 2002;120:1183-1188.

Background  We recently reported that acute retinal necrosis in humans develops in a setting where delayed hypersensitivity (DH) to the varicella-zoster virus (VZV) antigen was absent, implying that virus-specific DH mitigates against acute retinal necrosis.

Objective  To determine whether a similar correlation exists for patients with anterior uveitis caused by VZV.

Design  Using VZV and purified protein derivative (PPD) antigens to evaluate DH, we skin tested patients with acute, VZV-induced anterior uveitis (herpes zoster ophthalmicus [ZO-AU]) (n = 12), those with uveitis caused by VZV in the absence of dermatitis (zoster sine herpete [ZSH-AU]) (n = 3), and age-matched patients whose ophthalmic herpes zoster was unassociated with uveitis as controls (n = 7). Varicella-zoster virus–induced anterior uveitis was diagnosed by polymerase chain reaction methods and serum antibody titration. Serum samples were collected and analyzed for anti-VZV antibody titers. Anterior uveitis activity was assessed clinically. Delayed hypersensitivity skin tests were repeated in patients with zoster sine herpete 3 months after onset, when ocular recovery had taken place.

Results  All patients with VZV-induced skin disease alone (control group) displayed intense DH when tested with VZV and PPD antigens. By contrast, only 4 (33%) of 12 patients with ZO-AU had a positive DH to VZV, whereas 11 (91.6%) of these patients displayed positive PPD skin reactions. The clinical intensity of anterior uveitis correlated negatively with VZV DH responses (P<.05). Serum anti-VZV and anti–herpes simplex virus antibody titers were comparable in DH-positive VZV cases and in DH-negative patients with uveitis. Patients with uveitis and ZSH-AU also displayed absent VZV-specific DH, although their PPD responses were normal.

Main Outcome Measures  Varicella-zoster virus–specific DH, PPD-specific DH, VZV-specific antibody titration, and intraocular pressure in patients with ZO-AU.

Conclusions  Absence (or loss) of DH reactivity to VZV antigens seems to be a concomitant feature of VZV uveitis of high intensity, implying that virus-specific DH may interfere with the emergence of VZV-induced anterior uveitis, as it does for acute retinal necrosis.

Clinical Relevance  In a clinical setting, absence of virus-specific DH to anterior uveitis caused by VZV may not only reveal a possible pathogenic mechanism, but a negative DH response may prove useful in diagnosing ZSH-AU in the acute stage.


From the Department of Ophthalmology at Hachioji Medical Center (Dr Kezuka), and the Department of Ophthalmology at Tokyo Medical University (Drs Sakai, Minoda, Takeuchi, Keino, and Usui), Tokyo, Japan; and Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Mass (Dr Streilein).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inducible immune regulation following autoimmune disease in the immune-privileged eye
Kitaichi et al.
J. Leukoc. Biol. 2005;77:496-502.
ABSTRACT | FULL TEXT  

Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein
J. Leukoc. Biol. 2003;74:179-185.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.